Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall tone of the discussions reflects strong support for the adoption of TARGIT-IORT, with many emphasizing its benefits such as fewer non-cancer deaths, improved quality of life, and cost savings. Words like 'better,' 'more effective,' and 'game changer' convey enthusiasm, while references to specific data points reinforce deep engagement and recognition of its wide-ranging impact.
Most discussions strongly support the findings, emphasizing themes like better patient outcomes and system benefits, with phrases such as 'better for patients' and 'more effective,' indicating widespread agreement.
Posts demonstrate high curiosity and relevance, with frequent mention of travel savings, mortality reduction, and quality of life, showing the topic's importance to both clinicians and patients.
Many discussions delve into specifics, referencing trial results and potential healthcare improvements, which signifies deep engagement beyond surface-level reactions.
Several posts highlight the significant potential influence, citing thousands of lives saved, miles traveled saved, and improved treatment approaches, illustrating a perception of high impact on healthcare practices.
Benefits of TARGIT-IORT during lumpectomy for breast cancer: less travel, less pain, better quality of life, cosmetically superior & fewer non-breast cancer deaths. TARGIT-IORT should be offered when planning breast cancer surgery https://t.co/0aGrKqb9Xt 5/5
Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for patients, better for healthcare systems. By 2020, ~44,752 patients were treated, >20 million miles travel saved and ~ 2,000 deaths prevented. https://t.co/0S8quWDJhz
Time has come to share data with : Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) to improve breast cancer treatment – better for patients, better for health care systems - UCL Discovery https://t.co/mpkzFBjQnZ
Frontiers | Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for patients, better for healthcare systems https://t.co/o80nv20T0N
New research: Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for patients, better for healthcare systems: Micro abstract Targeted intraoperative radiotherapy (TARGIT-IORT) is… https://t.co/lDDezvIhIK #oncology
@Rad_Nation @ElenaSperk A2: If one now believes that ‘no tumour on ink’ is no worse than 1mm margin, then we could reasonably accept a ‘a negative margin’ as adequate enough to avoid supplemental EBRT. https://t.co/WvCo6ZpKws https://t.co/0aGrKqb9Xt #radonc #jc #bcsm
TARGIT-IORT during surgery improves breast cancer treatment outcomes, offering a targeted, single-dose radiotherapy option that is as effective as traditional therapy but with fewer associated risks and benefits for…
This lecture discusses the long-term results of the TARGIT randomized trial, showing that targeted intraoperative radiotherapy given during lumpectomy offers effective treatment with fewer risks and travel needs…
Full adoption of TARGIT-IORT during lumpectomy for breast cancer in UK would avoid 800 to 1000 deaths from other causes (cardiovascular, lung and other cancers) /year (⬆️ overall survival in grade 1 or 2) https://t.co/buFBGgdugN https://t.co/4ry5ZU3cUY https://t.co/0S8quWDJhz https://t.co/s1HpioVo82
RT @calaridge: Frontiers | Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for p…
RT @calaridge: Frontiers | Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for p…
RT @calaridge: Frontiers | Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for p…
RT @calaridge: Frontiers | Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for p…
Frontiers | Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for patients, better for healthcare systems https://t.co/o80nv20T0N
Also available at https://t.co/h2GeZKo4VC
RT @jsvaidya: Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for patients, bett…
RT @jsvaidya: Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for patients, bett…
RT @jsvaidya: Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for patients, bett…
RT @FrontOncology: New research: Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better…
Open Access UCL Research: Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for patients, better for healthcare systems https://t.co/s36iK0XP46
New research: Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for patients, better for healthcare systems: Micro abstract Targeted intraoperative radiotherapy (TARGIT-IORT) is… https://t.co/lDDezvIhIK #oncology
RT @jsvaidya: Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for patients, bett…
RT @jsvaidya: Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for patients, bett…
RT @jsvaidya: Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for patients, bett…
Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for patients, better for healthcare systems. By 2020, ~44,752 patients were treated, >20 million miles travel saved and ~ 2,000 deaths prevented. https://t.co/0S8quWDJhz
TARGIT-IORT during lumpectomy for #breastcancer is better for patients than whole-breast radiotherapy: As effective Greatly reduced non-breast-cancer deaths (10%→5%) Less pain & toxicity Improved quality of life & cosmetic outcome Lower cost to the NHS https://t.co/0aGrKqb9Xt
RT @enriquebargallo: Time has come to share data with : Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT)…
Time has come to share data with : Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) to improve breast cancer treatment – better for patients, better for health care systems - UCL Discovery https://t.co/mpkzFBjQnZ
The original paper describing long term results of TARGIT-A trial comparing risk-adapted single-dose TARGIT-IORT during lumpectomy for breast cancer vs. whole breast radiotherapy is here https://t.co/WvCo6ZpKws and a short video summary is here https://t.co/0aGrKqb9Xt
@Rad_Nation @ElenaSperk A2: If one now believes that ‘no tumour on ink’ is no worse than 1mm margin, then we could reasonably accept a ‘a negative margin’ as adequate enough to avoid supplemental EBRT. https://t.co/WvCo6ZpKws https://t.co/0aGrKqb9Xt #radonc #jc #bcsm
@ShrinivasDempo @ucl @GoaGmc @Navhind_Times And a video explaining the results is at https://t.co/0aGrKqb9Xt
RT @jsvaidya: Benefits of TARGIT-IORT during lumpectomy for breast cancer: less travel, less pain, better quality of life, cosmetically sup…
RT @jsvaidya: Benefits of TARGIT-IORT during lumpectomy for breast cancer: less travel, less pain, better quality of life, cosmetically sup…
RT @jsvaidya: Benefits of TARGIT-IORT during lumpectomy for breast cancer: less travel, less pain, better quality of life, cosmetically sup…
Benefits of TARGIT-IORT during lumpectomy for breast cancer: less travel, less pain, better quality of life, cosmetically superior & fewer non-breast cancer deaths. TARGIT-IORT should be offered when planning breast cancer surgery https://t.co/0aGrKqb9Xt 5/5